C-statistic of time to first therapy and overall survival
| . | . | OS . | TTFT . | ||||
|---|---|---|---|---|---|---|---|
| Cohort . | N . | IGHV . | IGHV, B2M, ABC . | CLL-IPI . | IGHV . | IGHV, B2M, ABC . | CLL-IPI . |
| Overall | 900 | 0.58 | 0.66 | 0.65 | 0.67 | 0.76 | 0.69 |
| MBL | 390 | 0.55 | 0.64 | 0.61 | 0.63 | 0.68 | 0.67 |
| Rai 0 CLL | 510 | 0.59 | 0.67 | 0.67 | 0.69 | 0.76 | 0.70 |
| . | . | OS . | TTFT . | ||||
|---|---|---|---|---|---|---|---|
| Cohort . | N . | IGHV . | IGHV, B2M, ABC . | CLL-IPI . | IGHV . | IGHV, B2M, ABC . | CLL-IPI . |
| Overall | 900 | 0.58 | 0.66 | 0.65 | 0.67 | 0.76 | 0.69 |
| MBL | 390 | 0.55 | 0.64 | 0.61 | 0.63 | 0.68 | 0.67 |
| Rai 0 CLL | 510 | 0.59 | 0.67 | 0.67 | 0.69 | 0.76 | 0.70 |
ABC, absolute B cell count.